Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China · Delayed Price · Currency is CNY 16.58
-1.86 (-10.09%)
Jul 13, 2026, 3:00 PM CST
SHA:688277 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -215.99 | -182.75 | -121.13 | -156.39 | -110.58 | -79.93 |
Depreciation & Amortization | 42.49 | 42.49 | 39.36 | 40.61 | 44.51 | 35.31 |
Other Amortization | 6.61 | 6.61 | 3.64 | 4.11 | 5.65 | 6.3 |
Loss (Gain) From Sale of Assets | -0 | -0 | -5.64 | -0 | 0.01 | - |
Asset Writedown & Restructuring Costs | 0.05 | 0.05 | 0.26 | 0.03 | 0.74 | 0.42 |
Loss (Gain) From Sale of Investments | -3.4 | -3.4 | -40.4 | -56.22 | -0.1 | -3.57 |
Provision & Write-off of Bad Debts | -0.96 | -0.96 | 6.21 | 2.38 | -2.53 | 5.77 |
Other Operating Activities | -33.56 | 4.23 | 9.51 | 5.03 | 2.19 | 0.63 |
Change in Accounts Receivable | 8.62 | 8.62 | -5.25 | -86.69 | -2.44 | -25.02 |
Change in Inventory | -16.45 | -16.45 | -5.56 | 14.07 | -6.1 | -3.31 |
Change in Accounts Payable | -19.75 | -19.75 | -33.06 | 26.92 | 11.97 | 20.18 |
Change in Other Net Operating Assets | 68.73 | 68.73 | 31.84 | 25.13 | 1 | -12.55 |
Operating Cash Flow | -122.2 | -51.17 | -98.65 | -170.5 | -87.51 | -77.76 |
Capital Expenditures | -27.86 | -29.71 | -36.69 | -221.03 | -59.59 | -238.66 |
Sale of Property, Plant & Equipment | -0.1 | - | 0.11 | 0.01 | - | - |
Divestitures | - | - | 52 | 11.81 | - | - |
Investment in Securities | -33.5 | -45.5 | 59.61 | -49.51 | 66.48 | 127.73 |
Other Investing Activities | 0.73 | 0.52 | 0.71 | 0.55 | 2.73 | 12.2 |
Investing Cash Flow | -60.73 | -74.7 | 75.74 | -258.17 | 9.62 | -98.73 |
Long-Term Debt Issued | - | 58.43 | 62.01 | 201.17 | 25 | - |
Long-Term Debt Repaid | - | -63.14 | -83.9 | -27.94 | -22.94 | -28.91 |
Net Debt Issued (Repaid) | -22.97 | -4.72 | -21.89 | 173.23 | 2.06 | -28.91 |
Issuance of Common Stock | 30.68 | 59.06 | - | 363.7 | - | 7.02 |
Common Dividends Paid | -7.16 | -7.18 | -9.06 | -4.68 | -0.76 | - |
Other Financing Activities | 53.7 | 57.21 | 29.16 | -3.94 | - | 17.08 |
Financing Cash Flow | 54.25 | 104.37 | -1.79 | 528.3 | 1.3 | -4.8 |
Foreign Exchange Rate Adjustments | -1.12 | -0.94 | 0.64 | -0.17 | 0.65 | - |
Net Cash Flow | -129.79 | -22.43 | -24.06 | 99.47 | -75.93 | -181.29 |
Free Cash Flow | -150.05 | -80.88 | -135.34 | -391.53 | -147.1 | -316.42 |
Free Cash Flow Margin | -54.97% | -29.01% | -75.68% | -186.41% | -94.18% | -202.80% |
Free Cash Flow Per Share | -0.32 | -0.18 | -0.30 | -0.88 | -0.35 | -0.75 |
Cash Income Tax Paid | 5.16 | 4.75 | 5.54 | -4.3 | -4.85 | 2.71 |
Levered Free Cash Flow | -11.51 | -2.14 | -90.1 | -307.34 | -111.36 | -315.47 |
Unlevered Free Cash Flow | -3.61 | 5.46 | -84.38 | -303.32 | -108.89 | -313.38 |
Change in Working Capital | 82.57 | 82.57 | 9.54 | -10.06 | -27.39 | -42.7 |